BioNano Genomics
Présence
BioNano Genomics est une société cotée sous le symbole boursier BNGO (US).
Dirigeants
Voir l'organigramme avec ses 28 principaux dirigeants
Biographies les plus recherchées chez BioNano Genomics
- Erik Holmlin, Director, President and Chief Executive Officer
- Kristiina Vuori, Director
- David Barker, Chairman of the Board
Changements de dirigeants chez BioNano Genomics
- Christopher Stewart, Chief Financial Officer, partira en retraite en sept. 2023 (publié le 15 août 2023).
- Gülsen Kama, a rejoint l'entreprise comme Chief Financial Officer (publié le 15 août 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez BioNano Genomics.
Biotechnologie
BioNano Genomics a 2 285 concurrents dont Lonza (Suisse), Eurofins (Luxembourg) et Adaptive Phage Therapeutics (Etats—Unis).
Actualités en fusion/acquisition en Biotechnologie.
- Karius vient d'annoncer une levée de fonds de 100 millions de dollars. (publié le 3 mai 2024).
- Transcarent vient d'annoncer une levée de fonds de 126 millions de dollars. (publié le 2 mai 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (publié le 2 mai 2024).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de BioNano Genomics
- BioNano Genomics sur Wikipédia, Google News & Yahoo Finance en 1-click
- BioNano Genomics sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Erik Holmlin 
Appelez BioNano Genomics au +1 858...
